Genetic biomarkers in cardiovascular disease
Genotype versus phenotype in cardiology: just a new coat of paint?
Genetic biomarkers in hypertrophic cardiomyopathy
Genetics in dilated cardiomyopathy
Genetic biomarkers in Brugada syndrome
Genetic biomarkers in aortopathy
The significance of MEN1 mutations in pituitary carcinomas
Mutational testing and its utility in thyroid cancer management: the need for something more
Elevated PRAME expression: what does this mean for treatment of head and neck squamous cell carcinoma?
Can biomarkers improve our approach to the treatment of early-stage cervical carcinoma?
Survival analysis reveals prognostic biomarkers
Telomerase predicts overall survival in patients with colorectal cancer
Exosomes and other microvesicles as new targets for cancer biomarker discovery
Conference Scene: Biomarkers: discovery technologies and novel disease applications
CYFRA21-1 as a serum tumor marker for follow-up patients with squamous cell lung carcinoma and oropharynx squamous cell carcinoma
Elevated expression of cancer/testis antigen FSIP1 in ER-positive breast tumors
Microsatellite instability affecting the T17 repeats in intron 8 of HSP110 , as well as five mononucleotide repeats in patients with colorectal carcinoma
Stability of miRNA in human urine supports its biomarker potential
A biomarker of oxidative stress as a nontraditional risk factor in obese subjects
Progress towards a consensus on biomarkers for Alzheimer’s disease: a review of peripheral analytes
Do hENT1 and RRM1 predict the clinical benefit of gemcitabine in pancreatic cancer?
Acknowledgements
Erratum